Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1956 1
1957 1
1958 2
1960 1
1967 3
1970 2
1971 1
1972 2
1973 3
1974 2
1975 1
1977 1
1978 2
1979 2
1980 2
1981 3
1982 3
1983 2
1984 2
1985 1
1986 2
1987 1
1988 1
1989 1
1990 1
1991 2
1992 2
1993 1
1995 3
1996 1
1997 1
1998 1
1999 2
2000 3
2001 1
2002 1
2003 1
2004 2
2005 7
2007 4
2008 5
2009 1
2010 3
2011 2
2012 7
2013 2
2014 4
2015 3
2016 3
2017 7
2018 6
2019 9
2020 10
2021 8
2022 9
2023 5
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
Moise KJ Jr, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocón-Hernández O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB; UNITY Study Group. Moise KJ Jr, et al. N Engl J Med. 2024 Aug 8;391(6):526-537. doi: 10.1056/NEJMoa2314466. N Engl J Med. 2024. PMID: 39115062 Clinical Trial.
FaceBase: A Community-Driven Hub for Data-Intensive Research.
Schuler RE, Bugacov A, Hacia JG, Ho TV, Iwata J, Pearlman L, Samuels BD, Williams C, Zhao Z, Kesselman C, Chai Y. Schuler RE, et al. J Dent Res. 2022 Oct;101(11):1289-1298. doi: 10.1177/00220345221107905. Epub 2022 Jul 31. J Dent Res. 2022. PMID: 35912790 Free PMC article. Review.
Parents are parenting and not visiting.
Schuler R, Mihatsch WA. Schuler R, et al. Acta Paediatr. 2024 Jun;113(6):1464. doi: 10.1111/apa.17202. Epub 2024 Mar 16. Acta Paediatr. 2024. PMID: 38491823 No abstract available.
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S, Bay J, Franz AR, Ehrhardt H, Klein L, Petzinger J, Binder C, Kirschenhofer S, Stein A, Hüning B, Heep A, Cloppenburg E, Muyimbwa J, Ott T, Sandkötter J, Teig N, Wiegand S, Schroth M, Kick A, Wurm D, Gebauer C, Linnemann K, Kittel J, Wieg C, Kiechl-Kohlendorfer U, Schmidt S, Böttger R, Thomas W, Brevis Nunez F, Stockmann A, Kriebel T, Müller A, Klotz D, Morhart P, Nohr D, Biesalski HK, Giannopoulou EZ, Hilt S, Poryo M, Wagenpfeil S, Haiden N, Ruckes C, Ehrlich A, Gortner L; NeoVitaA trial investigators. Meyer S, et al. Lancet Respir Med. 2024 Jul;12(7):544-555. doi: 10.1016/S2213-2600(24)00073-0. Epub 2024 Apr 18. Lancet Respir Med. 2024. PMID: 38643780 Clinical Trial.
FaceBase 3: analytical tools and FAIR resources for craniofacial and dental research.
Samuels BD, Aho R, Brinkley JF, Bugacov A, Feingold E, Fisher S, Gonzalez-Reiche AS, Hacia JG, Hallgrimsson B, Hansen K, Harris MP, Ho TV, Holmes G, Hooper JE, Jabs EW, Jones KL, Kesselman C, Klein OD, Leslie EJ, Li H, Liao EC, Long H, Lu N, Maas RL, Marazita ML, Mohammed J, Prescott S, Schuler R, Selleri L, Spritz RA, Swigut T, van Bakel H, Visel A, Welsh I, Williams C, Williams TJ, Wysocka J, Yuan Y, Chai Y. Samuels BD, et al. Among authors: schuler r. Development. 2020 Sep 21;147(18):dev191213. doi: 10.1242/dev.191213. Development. 2020. PMID: 32958507 Free PMC article. Review.
Cognitive function in SMA patients with 2 or 3 SMN2 copies treated with SMN-modifying or gene addition therapy during the first year of life.
Steffens P, Weiss D, Perez A, Appel M, Weber P, Weiss C, Stoltenburg C, Ehinger U, von der Hagen M, Schallner J, Claussen B, Lode I, Hahn A, Schuler R, Ruß L, Ziegler A, Denecke J, Johannsen J. Steffens P, et al. Among authors: schuler r. Eur J Paediatr Neurol. 2024 Jul;51:17-23. doi: 10.1016/j.ejpn.2024.05.002. Epub 2024 May 8. Eur J Paediatr Neurol. 2024. PMID: 38772209 Free article.
First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody.
Espié P, He Y, Koo P, Sickert D, Dupuy C, Chokoté E, Schuler R, Mergentaler H, Ristov J, Milojevic J, Verles A, Groenewegen A, Auger A, Avrameas A, Rotte M, Colin L, Tomek CS, Hernandez-Illas M, Rush JS, Gergely P. Espié P, et al. Among authors: schuler r. Am J Transplant. 2020 Feb;20(2):463-473. doi: 10.1111/ajt.15661. Epub 2019 Dec 6. Am J Transplant. 2020. PMID: 31647605 Free article. Clinical Trial.
165 results